Medwave 2020;20(7):e7996 doi: 10.5867/medwave.2020.07.7996
Acute amiodarone pulmonary toxicity with low impregnation dose: case report
Julio O Cabrera-Rego, José D Luzurriaga Navas, Alberto A Yanes Quintana
Key Words: amiodarone, pulmonary fibrosis, acute pulmonary toxicity
Abstract
Amiodarone, considered a potent antiarrhythmic, is known to cause pulmonary toxicity. Chronic interstitial pneumonitis is the most common presentation. However, acute pulmonary toxicity is rare and has a higher case fatality rate. We present a 61-year-old patient with persistent atrial fibrillation who, after a one-month treatment with oral amiodarone at a low dose impregnation of 400 mg/day, develops acute pulmonary toxicity, with radiographic and tomographic resolution after antiarrhythmic suspension and steroid treatment.
No English version is available for this article.
Esta
obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.
Se sabe que la amiodarona, un potente antiarrítmico, causa toxicidad pulmonar. La neumonitis intersticial crónica es la presentación más común. Sin embargo, la toxicidad pulmonar aguda es rara y provoca una mayor mortalidad. Se presenta un paciente de 61 años con fibrilación auricular persistente que, tras tratamiento por un mes con amiodarona vía oral a dosis baja de impregnación de 400 miligramos al día, desarrolló toxicidad pulmonar aguda secundaria al antiarrítmico confirmada por radiografía y tomografía. Su caso tuvo resolución después de la suspensión del fármaco y tratamiento con esteroides.
Authors:
Julio O Cabrera-Rego
[1], José D Luzurriaga Navas
[2], Alberto A Yanes Quintana
[1]
Affiliation:
[1] Unidad de Cuidados Coronarios Intensivos, Hospital Manuel Fajardo, La Habana, Cuba
[2] Departamento de Imagenología, Hospital Manuel Fajardo, La Habana, Cuba
E-mail: jocabrera@infomed.sld.cu
Author address:
[1] Zapata y D, Vedado, Plaza de La Revolución
La Habana, Cuba
Código postal: 10400
Citation:
Cabrera-Rego JO, Luzurriaga Navas JD, Yanes Quintana AA.
Acute amiodarone pulmonary toxicity with low impregnation dose: case report. Medwave 2020;20(7):e7996 doi: 10.5867/medwave.2020.07.7996
Submission date: 16/1/2020
Acceptance date: 25/7/2020
Publication date: 14/8/2020
Origin: Not commissioned
Type of review: Amiodarone, Pulmonary fibrosis, Acute pulmonary toxicity
Comments (0)
We are pleased to have your comment on one of our articles. Your comment will be published as soon as it is posted. However, Medwave reserves the right to remove it later if the editors consider your comment to be: offensive in some sense, irrelevant, trivial, contains grammatical mistakes, contains political harangues, appears to be advertising, contains data from a particular person or suggests the need for changes in practice in terms of diagnostic, preventive or therapeutic interventions, if that evidence has not previously been published in a peer-reviewed journal.
No comments on this article.
To comment please log in
Medwave provides HTML and PDF download counts as well as other harvested interaction metrics.
There may be a 48-hour delay for most recent metrics to be posted.
- Expósito ME, Fernández V, San Miguel MT. Fibrosis pulmonar asociada a amiodarona. A propósito de un caso. Farm Hosp. 1995;19(6):371-3. [On line]. | Link |
- Kaya SB, Deger S, Hacievliyagil SS, Aytemur ZA. Acute amiodarone toxicity causing respiratory failure. Rev Assoc Med Bras (1992). 2017 Mar;63(3):210-212. | CrossRef | PubMed |
- Singh VK, Maheshwari V. Acute Respiratory Distress Syndrome Complicated by Amiodarone Induced Pulmonary Fibrosis: Don't Let Your Guard Down. J Clin Diagn Res. 2017 Apr;11(4):UD01-UD02. | CrossRef | PubMed |
- Lohiya RV, Pethe MP. Early Recognition of Acute Pneumonitis in Amiodarone Treatment. Heart Views. 2018 Jul-Sep;19(3):109-113. | CrossRef | PubMed |
- Abuzaid A, Saad M, Ayan M, Kabach A, Haddad TM, Smer A, et al. Acute Amiodarone Pulmonary Toxicity after Drug Holiday: A Case Report and Review of the Literature. Case Rep Cardiol. 2015;2015:927438. | CrossRef | PubMed |
- Range FT, Hilker E, Breithardt G, Buerke B, Lebiedz P. Amiodarone-induced pulmonary toxicity--a fatal case report and literature review. Cardiovasc Drugs Ther. 2013 Jun;27(3):247-54. | CrossRef | PubMed |
- Lancha-Domínguez J, Ramírez-Sánchez MM, Páez-Rubio MI. Toxicidad pulmonar asociada a tratamiento con amiodarona. Rev Esp Casos Clin Med Intern (RECCMI). 2019; 4(2):57-60. | CrossRef |
- Schwaiblmair M, Berghaus T, Haeckel T, Wagner T, von Scheidt W. Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect? Clin Res Cardiol. 2010 Nov;99(11):693-700. | CrossRef | PubMed |
- Kharabsheh S, Abendroth CS, Kozak M. Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone. Am J Cardiol. 2002 Apr 1;89(7):896-8. | CrossRef | PubMed |
- Subban V, Kalidoss L, Lakshmanan A, Ajit MS. Acute amiodarone pulmonary toxicity in a patient with acute anterior wall myocardial infarction and ventricular tachycardia. Sahel Med J. 2013;16(4):165-7. | CrossRef |
- Bahena-López E, Bucio-Reta E, Bahena-López JP. Toxicidad pulmonar por amiodarona. Rev Invest Med Sur Mex. 2015;22(4):214-7. [On line]. | Link |
- Sánchez S, Zamora E, Hoyos N, Naranjo A, Al Nakeeb Z, Girón RM. Fibrosis pulmonar por amiodarona. Rev Patol Respir. 2006;9(2):77-80. [On line]. | Link |
- Jiménez López G, Alonso Orta I. Normas y procedimientos de trabajo del Sistema Cubano de Farmacovigilancia. La Habana: Ministerio de Salud Pública (MINSAP), Dirección Nacional de Medicamentos y Equipos Médicos; 2012.
Expósito ME, Fernández V, San Miguel MT. Fibrosis pulmonar asociada a amiodarona. A propósito de un caso. Farm Hosp. 1995;19(6):371-3. [On line]. |
Link |
Kaya SB, Deger S, Hacievliyagil SS, Aytemur ZA. Acute amiodarone toxicity causing respiratory failure. Rev Assoc Med Bras (1992). 2017 Mar;63(3):210-212. |
CrossRef |
PubMed |
Singh VK, Maheshwari V. Acute Respiratory Distress Syndrome Complicated by Amiodarone Induced Pulmonary Fibrosis: Don't Let Your Guard Down. J Clin Diagn Res. 2017 Apr;11(4):UD01-UD02. |
CrossRef |
PubMed |
Lohiya RV, Pethe MP. Early Recognition of Acute Pneumonitis in Amiodarone Treatment. Heart Views. 2018 Jul-Sep;19(3):109-113. |
CrossRef |
PubMed |
Abuzaid A, Saad M, Ayan M, Kabach A, Haddad TM, Smer A, et al. Acute Amiodarone Pulmonary Toxicity after Drug Holiday: A Case Report and Review of the Literature. Case Rep Cardiol. 2015;2015:927438. |
CrossRef |
PubMed |
Range FT, Hilker E, Breithardt G, Buerke B, Lebiedz P. Amiodarone-induced pulmonary toxicity--a fatal case report and literature review. Cardiovasc Drugs Ther. 2013 Jun;27(3):247-54. |
CrossRef |
PubMed |
Lancha-Domínguez J, Ramírez-Sánchez MM, Páez-Rubio MI. Toxicidad pulmonar asociada a tratamiento con amiodarona. Rev Esp Casos Clin Med Intern (RECCMI). 2019; 4(2):57-60. |
CrossRef |
Schwaiblmair M, Berghaus T, Haeckel T, Wagner T, von Scheidt W. Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect? Clin Res Cardiol. 2010 Nov;99(11):693-700. |
CrossRef |
PubMed |
Kharabsheh S, Abendroth CS, Kozak M. Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone. Am J Cardiol. 2002 Apr 1;89(7):896-8. |
CrossRef |
PubMed |
Subban V, Kalidoss L, Lakshmanan A, Ajit MS. Acute amiodarone pulmonary toxicity in a patient with acute anterior wall myocardial infarction and ventricular tachycardia. Sahel Med J. 2013;16(4):165-7. |
CrossRef |
Bahena-López E, Bucio-Reta E, Bahena-López JP. Toxicidad pulmonar por amiodarona. Rev Invest Med Sur Mex. 2015;22(4):214-7. [On line]. |
Link |
Sánchez S, Zamora E, Hoyos N, Naranjo A, Al Nakeeb Z, Girón RM. Fibrosis pulmonar por amiodarona. Rev Patol Respir. 2006;9(2):77-80. [On line]. |
Link |
Jiménez López G, Alonso Orta I. Normas y procedimientos de trabajo del Sistema Cubano de Farmacovigilancia. La Habana: Ministerio de Salud Pública (MINSAP), Dirección Nacional de Medicamentos y Equipos Médicos; 2012.